A new paper from the SHARP Clinical Research Collaboration, has been recently published in ERJ Open Research.
Entitled “Evaluation of Real-World Mepolizumab Use in Severe Asthma across Europe – the SHARP experience with privacy-preserving federated analysis”, the paper is from the SHARP COVID-19 imitative. It looks at vaccine rates in people with severe asthma, along side side effects and asthma control post vaccination.
